Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Leoutsakos JM, Forrester SN, Corcoran CD, Norton MC, Rabins PV, Steinberg MI, Tschanz JT, Lyketsos CG.

Int J Geriatr Psychiatry. 2015 Aug;30(8):824-32. doi: 10.1002/gps.4221. Epub 2014 Nov 3.

2.

(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.

Bell MG, Gernert DL, Grese TA, Belvo MD, Borromeo PS, Kelley SA, Kennedy JH, Kolis SP, Lander PA, Richey R, Sharp VS, Stephenson GA, Williams JD, Yu H, Zimmerman KM, Steinberg MI, Jadhav PK.

J Med Chem. 2007 Dec 27;50(26):6443-5. Epub 2007 Nov 27.

PMID:
18038968
3.

Azetidinones as vasopressin V1a antagonists.

Guillon CD, Koppel GA, Brownstein MJ, Chaney MO, Ferris CF, Lu SF, Fabio KM, Miller MJ, Heindel ND, Hunden DC, Cooper RD, Kaldor SW, Skelton JJ, Dressman BA, Clay MP, Steinberg MI, Bruns RF, Simon NG.

Bioorg Med Chem. 2007 Mar 1;15(5):2054-80. Epub 2006 Dec 23.

4.

3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists.

Neel DA, Brown ML, Lander PA, Grese TA, Defauw JM, Doti RA, Fields T, Kelley SA, Smith S, Zimmerman KM, Steinberg MI, Jadhav PK.

Bioorg Med Chem Lett. 2005 May 16;15(10):2553-7.

PMID:
15863315
5.

Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure.

Shen W, Gill RM, Zhang JP, Jones BD, Corbly AK, Steinberg MI.

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1508-14. Epub 2004 Nov 24.

6.
7.

Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes.

Wang J, Yu L, Solenberg PJ, Gelbert L, Geringer CD, Steinberg MI.

J Card Fail. 2002 Jun;8(3):167-74.

PMID:
12140810
9.

Identification, synthesis and pharmacological activity of moxonidine metabolites.

Wirth DD, He MM, Czeskis BA, Zimmerman KM, Roettig U, Stenzel W, Steinberg MI.

Eur J Med Chem. 2002 Jan;37(1):23-34.

PMID:
11841872
10.

Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.

Tanimura M, Mishima T, Steinberg MI, Borzak S, Goldstein S, Sabbah HN.

Cardiovasc Drugs Ther. 2000 Feb;14(1):77-82.

PMID:
10755204
11.

3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine.

Wiest SA, Steinberg MI.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):209-16.

PMID:
10494892
12.

Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.

Steinberg MI, Wiest SA, Pickard RT, Chen K, Shih JC.

Ann N Y Acad Sci. 1999 Jun 21;881:193-8. No abstract available.

PMID:
10415915
13.

Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes.

Yakubu-Madus FE, Johnson WT, Zimmerman KM, Dananberg J, Steinberg MI.

Diabetes. 1999 May;48(5):1093-100.

PMID:
10331415
14.
15.

Inhibitory Effects of LY301875 on Responses to Angiotensin Peptides in Pulmonary Vascular Bed of the Cat.

Kaye AD, Nossaman BD, Smith DE, DeWitt BJ, Steinberg MI, Kadowitz PJ, Ibrahim IN.

Am J Ther. 1996 Aug;3(8):568-573.

PMID:
11862292
16.

Effects of flecainide, encainide, and clofilium on ventricular refractory period extension by transcardiac shocks.

Sweeney RJ, Gill RM, Steinberg MI, Reid PR.

Pacing Clin Electrophysiol. 1996 Jan;19(1):50-60.

PMID:
8848377
17.

Effect of the imidazoline receptor ligand moxonidine on human platelet aggregation.

Wiest SA, Steinberg MI.

Ann N Y Acad Sci. 1995 Jul 12;763:606-9. No abstract available.

PMID:
7677380
18.
19.

Structural evolution and pharmacology of a novel series of triacid angiotensin II receptor antagonists.

Palkowitz AD, Steinberg MI, Thrasher KJ, Reel JK, Hauser KL, Zimmerman KM, Wiest SA, Whitesitt CA, Simon RL, Pfeifer W, et al.

J Med Chem. 1994 Dec 23;37(26):4508-21.

PMID:
7799401
21.

The reaction sequence of the Na+/K(+)-ATPase: rapid kinetic measurements distinguish between alternative schemes.

Pratap PR, Robinson JD, Steinberg MI.

Biochim Biophys Acta. 1991 Nov 4;1069(2):288-98.

PMID:
1657171
22.

Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists.

Wiest SA, Rampersaud A, Zimmerman K, Steinberg MI.

J Cardiovasc Pharmacol. 1991 Feb;17(2):177-84.

PMID:
1709220
23.

Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.

Steinberg MI, Wiest SA, Zimmerman KM, Ertel PJ, Bemis KG, Robertson DW.

J Pharmacol Exp Ther. 1991 Jan;256(1):222-9.

PMID:
1899116
24.
25.

Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain.

Gehlert DR, Gackenheimer SL, Reel JK, Lin HS, Steinberg MI.

Eur J Pharmacol. 1990 Oct 2;187(1):123-6.

PMID:
2272349
26.

Ventricular refractory period extension caused by defibrillation shocks.

Sweeney RJ, Gill RM, Steinberg MI, Reid PR.

Circulation. 1990 Sep;82(3):965-72.

PMID:
2394014
27.

Modification by glibenclamide of the electrophysiological consequences of myocardial ischaemia in dogs and rabbits.

Smallwood JK, Ertel PJ, Steinberg MI.

Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):214-20. Erratum in: Naunyn Schmiedebergs Arch Pharmacol 1990 Dec;342(6):726.

PMID:
2122259
28.

Binding and pharmacologic properties of peptides derived from human and rat angiotensin II (AII) mRNA.

Wiest SA, Gesellchen PD, Zimmerman K, Steinberg MI.

Biochem Biophys Res Commun. 1990 Jul 31;170(2):462-9.

PMID:
1974420
29.

Potassium channel modulators: scientific applications and therapeutic promise.

Robertson DW, Steinberg MI.

J Med Chem. 1990 Jun;33(6):1529-41. Review. No abstract available.

PMID:
2187993
30.

Atrial natriuretic peptide receptor modulators: effects of disubstituted quinazolines on receptor binding and in vitro biological activity.

Yu MJ, McCowan JR, Steinberg MI, Wiest SA, Wyss VL, Horng JS.

J Med Chem. 1990 Jan;33(1):348-53.

PMID:
1967315
31.

LY249933: a cardioselective 1,4-dihydropyridine with positive inotropic activity.

Holland DR, Wikel JH, Kauffman RF, Smallwood JK, Zimmerman KM, Utterback BG, Turk JA, Steinberg MI.

J Cardiovasc Pharmacol. 1989 Sep;14(3):483-91.

PMID:
2476630
32.

Electrophysiological effects of flecainide enantiomers in canine Purkinje fibres.

Smallwood JK, Robertson DW, Steinberg MI.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):625-9.

PMID:
2505091
33.

Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogue.

Robertson DW, Beedle EE, Wilson H, Parli CJ, Smallwood JK, Steinberg MI.

J Med Chem. 1988 Jul;31(7):1290-5.

PMID:
3385724
34.
35.

The relation between vascular relaxant and cardiac electrophysiological effects of pinacidil.

Steinberg MI, Ertel P, Smallwood JK, Wyss V, Zimmerman K.

J Cardiovasc Pharmacol. 1988;12 Suppl 2:S30-40.

PMID:
2466177
36.

Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogs.

Steinberg MI, Smallwood JK, Holland DR, Bymaster FP, Bemis KG.

Toxicol Appl Pharmacol. 1986 Jan;82(1):70-9.

PMID:
3484846
37.
38.

Pharmacologic and toxic effects in animals of dextropropoxyphene and its major metabolite norpropoxyphene: a review.

Nickander RC, Emmerson JL, Hynes MD, Steinberg MI, Sullivan HR.

Hum Toxicol. 1984 Aug;3 Suppl:13S-36S. Review. No abstract available.

PMID:
6090306
39.

Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues.

Steinberg MI, Wiest SA.

J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):614-21.

PMID:
6206315
40.

Correlation between the disposition of [14C]clofilium and its cardiac electrophysiological effect.

Lindstrom TD, Murphy PJ, Smallwood JK, Wiest SA, Steinberg MI.

J Pharmacol Exp Ther. 1982 Jun;221(3):584-9.

PMID:
7086672
41.

Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers.

Steinberg MI, Sullivan ME, Wiest SA, Rockhold FW, Molloy BB.

J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):881-95.

PMID:
6167818
42.

Clofilum--a new antifibrillatory agent that selectively increases cellular refractoriness.

Steinberg MI, Molloy BB.

Life Sci. 1979 Oct 15;25(16):1397-406. No abstract available.

PMID:
522607
43.

Recent congressional developments post Poelker and Gilbert--Congress confronts the abortion question.

Steinberg MI.

St Louis Univ Law J. 1979;22(4):596-600. No abstract available.

PMID:
11663940
44.

Electrophysiologic properties of propoxyphene and norpropoxyphene in canine cardiac conducting tissues in vitro and in vivo.

Holland DR, Steinberg MI.

Toxicol Appl Pharmacol. 1979 Jan;47(1):123-33. No abstract available.

PMID:
425111
45.

Calcium fluxes and contractility in isolated guinea pig atrium: effect of A23187.

Holland DR, Armstrong WM, Steinberg MI.

Am J Physiol. 1978 Jul;235(1):C13-9.

PMID:
354412
47.

The California Natural Death Act--a failure to provide for adequate patient safeguards and individual autonomy.

Steinberg MI.

Conn Law Rev. 1977 Winter;9(2):203-26. No abstract available.

PMID:
11661836
48.

Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.

Nickander R, Smits SE, Steinberg MI.

J Pharmacol Exp Ther. 1977 Jan;200(1):245-53.

PMID:
13200
49.
50.

A23187: a calcium ionophore that directly increases cardiac contractility (38704).

Holland DR, Steinberg MI, Armstrong WM.

Proc Soc Exp Biol Med. 1975 Apr;148(4):1141-5.

PMID:
1093199

Supplemental Content

Loading ...
Support Center